6:59<br>著名な毒性学者によるイベルメクチンの安全性評価<br><a href="https://alzhacker.com/expert-review-report-medical-safety-of-ivermectin/" target="_blank" rel="noopener nofollow">https://alzhacker.com/expert-review-report-medical-safety-of-ivermectin/</a><br><br>7:20<br>イベルメクチンの作用機序<br><a href="https://www.nature.com/articles/s41429-021-00430-5" target="_blank" rel="noopener nofollow">https://www.nature.com/articles/s41429-021-00430-5</a><br><br>7:40<br>ペルー国民における全症例死亡数<br><a href="https://www.sciencedirect.com/science/article/pii/S2052297521000883" target="_blank" rel="noopener nofollow">https://www.sciencedirect.com/science/article/pii/S2052297521000883</a><br><br>8:14<br>イベルメクチンのCOVID-19に対する臨床試験の世界的動向<br><a href="https://kitasato-infection-control.info/swfu/d/ivermectin_20210330_j.pdf" target="_blank" rel="noopener nofollow">https://kitasato-infection-control.info/swfu/d/ivermectin_20210330_j.pdf</a><br><br>8:30<br>オックスフォード大学PRINCIPLE試験<br><a href="https://www.principletrial.org/" target="_blank" rel="noopener nofollow">https://www.principletrial.org/</a><br><br>11:20<br>イベルメクチンに対する公衆衛生機関の不規則な行動と広範な 虚偽情報キャンペーンに関する FLCCC アライアンスの声明 <br><a href="https://kitasato-infection-control.info/swfu/d/ivermectin_20210518_j.pdf" target="_blank" rel="noopener nofollow">https://kitasato-infection-control.info/swfu/d/ivermectin_20210518_j.pdf</a><br><br>11:40<br>Romanらのメタアナリシスの問題<br><a href="https://alzhacker.com/the-meta-analytical-fixers-an-ivermectin-tale/" target="_blank" rel="noopener nofollow">https://alzhacker.com/the-meta-analytical-fixers-an-ivermectin-tale/</a><br><br>18:00<br>エジプト Alcazar教授の研究について<br><a href="https://alzhacker.com/darkhorse-podcast-with-tess-lawrie-bret-weinstein/" target="_blank" rel="noopener nofollow">https://alzhacker.com/darkhorse-podcast-with-tess-lawrie-bret-weinstein/</a><br><br>20:00<br>WHOの利益相反<br><a href="https://alzhacker.com/conflict-of-interest-in-who-recommendation-against-ivermectin/" target="_blank" rel="noopener nofollow">https://alzhacker.com/conflict-of-interest-in-who-recommendation-against-ivermectin/</a><br><br>21:25<br>メルクの新薬とIVMの拒否<br><a href="https://alzhacker.com/horowitz-merck-rejects-ivermectin-for-covid-treatment/" target="_blank" rel="noopener nofollow">https://alzhacker.com/horowitz-merck-rejects-ivermectin-for-covid-treatment/</a><br><br>イベルメクチン研究の総数　63件<br>プラスの効果を報告している研究の数　58件<br><a href="https://ivmmeta.com/" target="_blank" rel="noopener nofollow">https://ivmmeta.com/</a> （リアルタイムメタ分析）